About the Company
DFO Management (formerly MSD Capital) is an American family office that manages the capital of Michael Dell and his family. The firm, which is based in New York and has offices in Santa Monica and West Palm Beach, was formed in 1998.
Employees
2
Exchange
NASDAQ
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $MSDA News
MSD Acquisition Corp Class A
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Michael Dell Forms New ‘Blank Check’ SPAC, Seeks $575M IPO
“MSD Acquisition Corp. is a newly organized blank check company incorporated as a Cayman Islands exempted company for the purpose of effecting a merger, share exchange, asset ...
Michael Dell’s New SPAC And IPO: 5 Big Things To Know
From who runs MSD Acquisition to the type of companies its targeting to buy, CRN breaks down the five biggest things to know about Michael Dell’s newly formed acquisition company. 5 Keys To MSD ...
MSD Acquisition Corp. (MSDA)
*Close price adjusted for splits.**Adjusted close price adjusted for splits and dividend and/or capital gain distributions. Loading more data ...
Dayton's largest mechanical contractor plans $4.6 million expansion
The company's original facility ... 4406 Springfield St. The total investment by MSD Inc. would come in around $4.7 million, including the land acquisition and construction. Over $4 million ...
Gregg Lemkau's Net Worth
This is based on reported shares across multiple companies, which include MSD ACQUISITION CORP. / NEW, Dine Brands Global, Inc., and MSD Investment Corp..
IPO-Bound BYJU’s In Talks With 4 SPACs For U.S Listing: Report
The three contenders include Churchill Capital, MSD Acquisition Corp and Harry Sloan. Report claims Churchill’s Klein offered the decacorn $500 Mn along with investments from Y Combinator’s ...
Abceutics, Inc., a startup at UB, acquired by biopharma company Merck
Balthasar, PhD, has been acquired by the global biopharmaceutical company Merck, known as MSD outside the U.S. and Canada. Merck acquired Abceutics for a potential consideration of up to $208 million, ...
Merck completes Harpoon Therapeutics acquisition
Merck (MSD) has concluded the acquisition of Harpoon Therapeutics ... to acquire all the outstanding shares of the US-based company for $680m. Harpoon will function as a wholly-owned subsidiary ...
Patented AI Platform Identifies Promising Early-Stage BioPharma Assets and Companies
Fierce competition. Thin pipelines. Patent cliffs. The stakes are sky-high for pharmaceutical companies and investors alike.
Loading the latest forecasts...